Singapore markets closed
  • Straits Times Index

    3,208.86
    -8.55 (-0.27%)
     
  • S&P 500

    4,288.05
    -11.65 (-0.27%)
     
  • Dow

    33,507.50
    -158.80 (-0.47%)
     
  • Nasdaq

    13,219.32
    +18.02 (+0.14%)
     
  • Bitcoin USD

    28,260.83
    +1,107.88 (+4.08%)
     
  • CMC Crypto 200

    605.91
    +27.14 (+4.69%)
     
  • FTSE 100

    7,571.26
    -36.82 (-0.48%)
     
  • Gold

    1,852.80
    -13.30 (-0.71%)
     
  • Crude Oil

    91.20
    +0.41 (+0.45%)
     
  • 10-Yr Bond

    4.5730
    0.0000 (0.00%)
     
  • Nikkei

    31,759.88
    -97.72 (-0.31%)
     
  • Hang Seng

    17,809.66
    +436.66 (+2.51%)
     
  • FTSE Bursa Malaysia

    1,418.76
    -5.41 (-0.38%)
     
  • Jakarta Composite Index

    6,961.46
    +21.57 (+0.31%)
     
  • PSE Index

    6,304.53
    -16.71 (-0.26%)
     

3 No-Brainer Stocks to Buy for Under $100 Right Now

3 No-Brainer Stocks to Buy for Under $100 Right Now

Here's why they chose CRISPR Therapeutics (NASDAQ: CRSP), Novocure (NASDAQ: NVCR), and Pfizer (NYSE: PFE). David Jagielski (CRISPR Therapeutics): Shares of CRISPR Therapeutics are trading below $70, but it may not be long before they take off. The company has a promising gene-editing therapy in exa-cel for rare blood disorders beta-thalassemia and sickle cell disease that it has been working on with Vertex Pharmaceuticals.